One may suggest a rise in the SP because of the coming CR explains the miss. It's not really price for much growth so any even if from acquisitions is a positive.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025